Cardiff Oncology, Inc.
No trades
No trades
Fundamentals and stats
EPS and revenue snapshot
In the last quarter, the company reported −0.14 USD per share, beating the −0.12 USD estimate by −17.02%. Revenue for the same period reached 104.00 K USD, despite the estimate of 62.78 K USD. For the next quarter, analysts expect −0.14 USD in earnings per share and 81.43 K USD in revenue.
Next report date—
Report period—
EPS estimate—
Revenue estimate—
EPS
Reported
Estimate
Metrics
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Metrics
Reported
Estimate
Surprise